4.5 Article

IL-1β-Induced Accumulation of Amyloid: Macroautophagy in Skeletal Muscle Depends on ERK

Journal

MEDIATORS OF INFLAMMATION
Volume 2017, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2017/5470831

Keywords

-

Funding

  1. German Research Foundation
  2. Open Access Publication Funds of the Gottingen University
  3. Swiss National Science Foundation [310030_162560]
  4. Swiss National Science Foundation (SNF) [310030_162560] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

The pathology of inclusion body myositis (IBM) involves an inflammatory response and beta-amyloid deposits in muscle fibres. It is believed that MAP kinases such as the ERK signalling pathway mediate the inflammatory signalling in cells. Further, there is evidence that autophagic activity plays a crucial role in the pathogenesis of IBM. Using a well established in vitro model of IBM, the autophagic pathway, MAP kinases, and accumulation of beta-amyloid were examined. We demonstrate that stimulation of muscle cells with IL-1 beta and IFN-gamma led to an increased phosphorylation of ERK. The ERK inhibitor PD98059 diminished the expression of proinflammatory markers as well as the accumulation of beta-amyloid. In addition, IL-1 beta and IFN-gamma led to an increase of autophagic activity, upregulation of APP, and subsequent accumulation of beta-sheet aggregates. Taken together, the data demonstrate that the ERK pathway contributes to formation of beta-amyloid and regulation of autophagic activity in muscle cells exposed to proinflammatory cell stress. This suggests that ERK serves as an important mediator between inflammatory mechanisms and protein deposition in skeletal muscle and is a crucial element of the pathology of IBM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation

Christian W. Keller, Monika B. Kotur, Sarah Mundt, Nikolaos Dokalis, Laure-Anne Ligeon, Ajay M. Shah, Marco Prinz, Burkhard Becher, Christian Muenz, Jan D. Lueneman

Summary: This study reveals that the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 in conventional dendritic cells (cDCs) regulates MOG antigen processing through LC3-associated phagocytosis (LAP), enabling encephalitogenic T helper cells to initiate and sustain autoimmune neuroinflammation. Genetic ablation of Cybb in cDCs restrains T-H cell recruitment into the CNS and ameliorates clinical disease development upon the adoptive transfer of MOG-specific CD4(+) T cells.

AUTOPHAGY (2021)

Article Cell Biology

ATG5 in microglia does not contribute vitally to autoimmune neuroinflammation in mice

Keertana Srimat Kandadai, Monika B. Kotur, Nikolaos Dokalis, Irmgard Amrein, Christian W. Keller, Christian Muenz, David Wolfer, Marco Prinz, Jan D. Luenemann

Summary: The study shows that the loss of ATG5 in adult microglia does not affect CNS tissue integrity, microglial cell survival, immune activation, learning task performance, or the development of experimental autoimmune encephalomyelitis. This suggests that ATG5 expression in microglia is not essential for maintaining CNS homeostasis or for the development of autoimmune neuroinflammation.

AUTOPHAGY (2021)

Article Clinical Neurology

Impact of complement activation on clinical outcomes in multiple sclerosis

Christian W. Keller, Johanna Oechtering, Heinz Wiendl, Ludwig Kappos, Jens Kuhle, Jan D. Luenemann

Summary: The study showed that activation profiles of complement pathways in early relapse-onset MS patients were not correlated with disease activity, suggesting that complement activation products are not suitable biomarkers for assessing disease activity in early MS.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Review Virology

Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses

Christian Munz

Summary: The oncogenes encoded by EBV and KSHV manipulate cellular processes like autophagy, proliferation, and apoptosis to ensure their efficient persistence and dissemination in hosts without causing pathologies in most carriers. These mechanisms allow the viruses to strike a balance between infectivity and host immune response, preventing clearance and minimizing symptoms.

VIRUSES-BASEL (2021)

Review Oncology

Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein-Barr Virus

Yun Deng, Christian Muenz

Summary: Epstein-Barr virus (EBV) infects over 95% of the adult human population, usually controlled by immune responses. Genetic variations affect cytotoxic lymphocytes' role in immune control against EBV. Humanized mice models offer insights into molecular mechanisms during EBV infection and potential vaccine development.

CANCERS (2021)

Letter Clinical Neurology

Reply to Investigating the Immunopathogenic Mechanisms Underlying MOGAD REPLY

Christian W. Keller, Joseph A. Lopez, Eva-Maria Wendel, Sudarshini Ramanathan, Catharina C. Gross, Luisa Klotz, Markus Reindl, Russell C. Dale, Heinz Wiendl, Kevin Rostasy, Fabienne Brilot, Jan D. Lunemann

ANNALS OF NEUROLOGY (2022)

Review Biochemistry & Molecular Biology

Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection

Christian Muenz

Summary: The Epstein Barr virus can be controlled by the immune system in most carriers, but deficiencies in certain molecular pathways can lead to EBV-associated pathologies. Co-stimulatory and co-inhibitory molecules play a crucial role in EBV-specific immune control.

BIOMOLECULES (2022)

Review Clinical Neurology

Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options

Rachel Zeng, Stefanie Glaubitz, Jens Schmidt

Summary: Inflammatory myopathies, or myositis, are rare diseases characterized by progressive muscle weakness, with each subtype having different autoantibody profiles, histological findings, and extramuscular manifestations. New molecular pathways for targeted therapy have been discovered due to a better understanding of the muscle inflammation's pathogenesis in myositis. Current therapies aim at different components of the immune response, and therapeutical antibodies have shown promising results in clinical trials.

NEUROTHERAPEUTICS (2022)

Letter Clinical Neurology

Complement activation contributes to GAD antibody-associated encephalitis

Omar Chuquisana, Christine Strippel, Anna M. Troscher, Tobias Baumgartner, Attila Racz, Christian W. Keller, Christian E. Elger, Nico Melzer, Stjepana Kovac, Heinz Wiendl, Jan Bauer, Jan D. Lunemann

ACTA NEUROPATHOLOGICA (2022)

Article Clinical Neurology

Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis

Christian W. Keller, Omar Chuquisana, Judith Derdelinckx, Catharina C. Gross, Klaus Berger, James Robinson, Falk Nimmerjahn, Heinz Wiendl, Nick Willcox, Jan D. Luenemann

Summary: This study found that FcγRIIB expression levels are significantly reduced in B lineage cells derived from early-onset MG patients, and genetic variants associated with impaired FcγRIIB expression are not common in MG, suggesting that post-transcriptional dysregulation plays an important role in the disease.

ANNALS OF NEUROLOGY (2022)

Article Clinical Neurology

Impairment of muscular endothelial cell regeneration in dermatomyositis

D. Lemmer, J. Schmidt, K. Kummer, B. Lemmer, A. Wrede, C. Seitz, P. Balcarek, K. Schwarze, G. A. Mueller, D. Patschan, S. Patschan

Summary: This study aimed to compare parameters of early endothelial progenitor cell (eEPC) integrity in patients with dermatomyositis (DM), necrotizing myopathy (NM), and non-myopathic controls. The findings showed a loss of intramuscular microvessels and endothelial activation in DM patients. Vascular regeneration was impaired in both DM and NM. These findings suggest the role of inflammation-associated vascular damage in the pathogenesis of DM.

FRONTIERS IN NEUROLOGY (2022)

Review Cell Biology

Altered Immune Response to the Epstein-Barr Virus as a Prerequisite for Multiple Sclerosis

Fabienne Laederach, Christian Muenz

Summary: Strong epidemiologic evidence supports the association between Epstein-Barr virus (EBV) infection and altered immune control to the development of multiple sclerosis (MS). The mechanisms linking the two remain largely unknown. Two main possibilities for this association are discussed. Immune responses induced during a symptomatic primary EBV infection might be amplified over time, leading to central nervous system inflammation and demyelination. Alternatively, genetic predisposition and environmental factors may result in insufficient immune control of EBV-infected B cells, leading to autoimmune T cell stimulation or CNS inflammation. Understanding EBV's contribution to MS could potentially open new treatment possibilities for this autoimmune disease.

CELLS (2022)

Article Clinical Neurology

Complement activation profiles in anti-acetylcholine receptor positive myasthenia gravis

Frauke Stascheit, Omar Chuquisana, Christian W. Keller, Philip Alexander Ambrose, Sarah Hoffmann, Catharina C. Gross, Sophie Lehnerer, Heinz Wiendl, Nick Willcox, Andreas Meisel, Jan D. Luenemann

Summary: In patients with AChR-Ab(+) MG, there is significantly increased activation of the complement system, which remains present even under standard immunosuppressive therapies but is not evident in patients with MuSK-Abs or seronegative MG. Further exploration of complement inhibition proximal to C5 cleavage is suggested for potential therapeutic benefits in AChR-Ab(+) MG.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Immunology

Autophagy pathways in autoimmune diseases

Christian W. Keller, Iannis E. Adamopoulos, Jan D. Luenemann

Summary: Autophagy plays important roles in response to energy deprivation, organelle turnover and proteostasis. It has been increasingly linked to various aspects of immunity, including host defence against pathogens and antigen presentation. Deregulated autophagy pathways can contribute to autoimmune responses.

JOURNAL OF AUTOIMMUNITY (2023)

Article Rheumatology

Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey

M. Weiss, M. T. Holzer, F. Muehlensiepen, Y. Ignatyev, C. Fiehn, J. Bauhammer, J. Schmidt, S. Schlueter, A. Dihkan, D. Scheibner, U. Schneider, L. Valor-Mendez, G. Corte, L. Gupta, H. Chinoy, I. Lundberg, L. Cavagna, J. H. W. Distler, G. Schett, J. Knitza

Summary: This study investigated the symptoms, diagnostic delay, medical care, health status, working status, disease knowledge, and willingness to participate in research of ASSD patients by conducting an international web-based survey. The results highlight the significance of internet-based research in gaining insights and understanding rare diseases among patients.

RHEUMATOLOGY INTERNATIONAL (2023)

No Data Available